Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2023

Management of central nervous system (CNS) disease in HER2+ in metastatic breast cancer  

Imaging modalities to diagnose and assess CNS disease in metastatic breast cancer: Which to choose and when

Date

03 Dec 2023

Session

Management of central nervous system (CNS) disease in HER2+ in metastatic breast cancer  

Topics

Radiological Imaging;  Nuclear Medicine and Clinical Molecular Imaging;  Response Evaluation (RECIST Criteria)

Tumour Site

Breast Cancer

Presenters

Gabriel Garcia

Authors

G. Garcia

Author affiliations

  • Gustave Roussy - Cancer Campus, 94805 - Villejuif/FR

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Presentation of case/condition

Presenter: Samuel Ow

Session: Management of central nervous system (CNS) disease in HER2+ in metastatic breast cancer  

Resources:

Slides

Webcast

Q&A and discussion

Presenter: All Speakers

Session: Management of central nervous system (CNS) disease in HER2+ in metastatic breast cancer  

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.